Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beverly Winikoff

Showing results (81-90 of 204) with videos related to

Pageof 21
Sort By:
Contraception|July 6, 2015
A prospective, non-randomized study of home use of mifepristone for medical abortion in the U.SErica Chong, Laura J Frye, Jen Castle, et al.
Obstetrics and Gynecology|January 23, 2010
Alternatives to a routine follow-up visit for early medical abortionWesley Clark, Hillary Bracken, Jini Tanenhaus, et al.
Reproductive Health Matters|February 23, 2015
The introduction of first trimester medical abortion in ArmeniaKarmen S Louie, Erica Chong, Tamar Tsereteli, et al.
The Pan African Medical Journal|December 4, 2014
[First experience of the use of misoprostol as post-abortion care in Libreville, Gabon]Sosthène Mayi-Tsonga, Ulysse Minkobame, Arielle Mbila, et al.
Contraception|January 15, 2004
The medical abortion experiences of married and unmarried women in Tunis, TunisiaJennifer Blum, Selma Hajri, Hela Chélli, et al.
Biomarkers in Medicine|April 11, 2023
PAPP-A as a screening tool for assessment of gestational age before medication abortion in an intended-use populationLaura J Frye, Irina A Buhimschi, Elizabeth G Raymond, et al.
Contraception|January 15, 2022
"Who is driving you home today?" Escort policies as a barrier to abortion accessAlice Mark, Reesa Roberts, Angel M Foster, et al.
Contraception|January 13, 2009
Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostolSheila Raghavan, Rodica Comendant, Irena Digol, et al.
Contraception|November 26, 2005
A randomized controlled study comparing 600 versus 1,200 microg oral misoprostol for medical management of incomplete abortionThi Nhu Ngoc Nguyen, Jennifer Blum, Jill Durocher, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 17, 2005
Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trialGijs Walraven, Jennifer Blum, Yusupha Dampha, et al.
Pageof 21

Showing results (81-90 of 204) with videos related to

Sort By:
Pageof 21
Contraception|July 6, 2015
A prospective, non-randomized study of home use of mifepristone for medical abortion in the U.SErica Chong, Laura J Frye, Jen Castle, et al.
Obstetrics and Gynecology|January 23, 2010
Alternatives to a routine follow-up visit for early medical abortionWesley Clark, Hillary Bracken, Jini Tanenhaus, et al.
Reproductive Health Matters|February 23, 2015
The introduction of first trimester medical abortion in ArmeniaKarmen S Louie, Erica Chong, Tamar Tsereteli, et al.
The Pan African Medical Journal|December 4, 2014
[First experience of the use of misoprostol as post-abortion care in Libreville, Gabon]Sosthène Mayi-Tsonga, Ulysse Minkobame, Arielle Mbila, et al.
Contraception|January 15, 2004
The medical abortion experiences of married and unmarried women in Tunis, TunisiaJennifer Blum, Selma Hajri, Hela Chélli, et al.
Biomarkers in Medicine|April 11, 2023
PAPP-A as a screening tool for assessment of gestational age before medication abortion in an intended-use populationLaura J Frye, Irina A Buhimschi, Elizabeth G Raymond, et al.
Contraception|January 15, 2022
"Who is driving you home today?" Escort policies as a barrier to abortion accessAlice Mark, Reesa Roberts, Angel M Foster, et al.
Contraception|January 13, 2009
Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostolSheila Raghavan, Rodica Comendant, Irena Digol, et al.
Contraception|November 26, 2005
A randomized controlled study comparing 600 versus 1,200 microg oral misoprostol for medical management of incomplete abortionThi Nhu Ngoc Nguyen, Jennifer Blum, Jill Durocher, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 17, 2005
Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trialGijs Walraven, Jennifer Blum, Yusupha Dampha, et al.
Pageof 21